O&G JC107: Abnormal Vaginal Bleeding: Gynaecological Cancer Flashcards

1
Q

Common cause of abnormal vaginal bleeding

A

Benign causes:
Uterine (PALM):
1. Endometrial polyps
2. Adenomyosis
3. Fibroids
4. Endometrial hyperplasia
5. Pregnancy-related
6. Dysfunctional uterine bleeding (i.e. without identifiable cause)

Ovarian:
1. Anovulation

Cervical:
1. Cervical polyps
2. Cervical erosion

Vaginal:
1. Atrophic vaginitis
2. Lacerations

Malignant causes:
- Can occur at any part of genital tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How to tell source of bleeding: History taking

A
  1. Age + ***Stage of reproductive life
    - Pre-menarche
    - Pregnant
    - Peri-menopausal
    - Post-menopausal
  2. Bleeding pattern / Menstrual history
    - **Amount
    - **
    Regular / Irregular
    - **Abnormal bleeding
    –> **
    Intermenstrual bleeding (Endometrial cancer)
    –> **Post-menopausal bleeding (Endometrial cancer)
    –> **
    Post-coital bleeding (Cervical cancer)
    –> Clots
  3. Provoking factors
    - **Coitus
    - **
    Trauma (vaginal lacerations)
    - ***Stress (e.g. medical students) –> Hypothalamic amenorrhoea
  4. Associated symptoms
    - **Abdominal pain
    - **
    Urinary / Bowel symptoms (e.g. Uterine fibroids may cause pressure symptoms on urinary bladder –> urinary frequency) (also rule out **haematuria / **blood in stools mistaken as vaginal bleeding)
    - Anaemic symptoms

***記: COC (Contraceptive, Obstetrics, Cervical smear)
5. Contraceptive history
- possibility of pregnancy?
- on hormones e.g. OC pills?

  1. Obstetric history
  2. Cervical smear history
    - smear up to date?
    - have regular smear?
    - smear results
  3. Drug history
    - **Anticoagulation (cause menorrhagia)
    - **
    HRT (cause abnormal uterine bleeding)
    - **OC pills
    - **
    Herbal medications (may contain estrogen)
  4. Family history
    - CA ovary, breast, colon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Physical examination

A

General examination
1. Pallor
2. Bleeding tendency (e.g. easy bruising)
3. Constitutional symptoms (e.g. cachexia)

Abdominal examination
1. Inspection
- Scars
- **Distension (e.g. ovarian mass, ascites, pregnancy)
- **
Signs of pregnancy (e.g. linea nigra, fetal movement in advanced gestation)

  1. Palpation
    - Mass
    - Tenderness (e.g. elicit rebound, guarding for peritoneal signs)
  2. Percussion
    - Ascites
  3. Auscultation
    - Fetal heart

Pelvic examination
1. Inspection
- Vulva
- Vagina / Cervix (by Speculum examination)
—> **Lesions / Bleeding sites
—> **
Atrophic changes
—> ***Genital prolapse (cause ulcers)

  1. Bimanual examination of Uterus
    - Position (Anteverted, Retroverted, Axial)
    - Size
    - Mobility
    - ***Adnexal masses (estimate size)
  2. Rectal examination
    - Endometriosis (nodularity in PoD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Investigations

A

Cervix
1. **Cervical smear
- collect cells from cervix for cytological diagnosis
- for cervical cancer screening, effective in picking up abnormal cells from cervix before obvious lesion / cervical cancer become apparent
- abnormal smear –> proceed to **
Colposcopy

  1. Colposcopy
    - examination of cervix with Colposcope
    - apply Acetic acid –> Lugol’s iodine to cervix to visualise abnormal lesions
    - lesions seen –> proceed to Cervical biopsy for histological diagnosis
  2. ***Cervical biopsy
    - punch biopsy
    - obvious lesion / mass at cervix
    - histological diagnosis

Uterus
1. ***Endometrial aspirate (biopsy)
- Pipelle aspirator (can be performed in clinic)

  1. ***Hysteroscopy (Diagnostic)
    - visualise uterine cavity
  2. **Hysteroscopy + **Curettage (H+C)
    - can be performed during Hysteroscopy to ascertain any endometrial pathology
  3. USG
    - Transvaginal / Transabdominal
    - readily available
    - look at endometrial ***thickness, other pathologies
    - sagittal view of uterus: Trilaminar layer of endometrium
    –> outer echogenic basal layer
    –> middle hypoechoic functional layer
    –> inner echogenic stripe at the central interface
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Common gynaecological cancers

A
  1. Cervical cancer –> cause abnormal vaginal bleeding
  2. Endometrial cancer –> cause abnormal vaginal bleeding
  3. Ovarian cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Epidemiology of gynaecological cancers

A

Endometrial cancer (Corpus uteri cancer)
- 4th most common female cancer
- 11th in mortality
- Median age at diagnosis: 55
- ↑ incidence in HK (associated to risk factors e.g. obesity)
- 70% presents at stage 1 (∵ mostly symptomatic)

Ovarian cancer
- 6th

Cervical cancer
- 7th
- 8th in mortality
- Median age at diagnosis: 54
- 25% presents at stage 1, 25% stage 2, 40% stage 3+4 (advanced stage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

***Risk factors for Cervical cancer

A
  1. ***HPV
  2. Early sex
  3. Multiple sex partners
  4. STD
  5. Smoking
  6. Lower socioeconomic class
  7. OC pills
  8. Immunosuppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

***Clinical features of Cervical cancer (SpC OG + Felix Lai)

A
  1. Asymptomatic
  2. Bleeding
    - Irregular menstrual bleeding
    - Heavy menstrual bleeding
    - Intermenstrual bleeding
    - ***Post-coital bleeding (most specific presentation of cervical cancer, DDx: cervicitis)
  3. Vaginal discharge
    - Blood stained or unpleasant smell
  4. Metastatic symptoms
    - Bowel and urinary changes (invasion into bladder / rectum)
    —> Haematuria, Haematochezia
    - Constitutional symptoms
    - Dyspnea
    - Jaundice
    - Pelvic or low back pain (bone pain)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

History taking of Cervical cancer

A
  1. Age
    - Median 54
  2. Bleeding pattern
    - ***Post-coital bleeding
  3. Associated symptoms
    - Early disease: ***not much (usually picked up during cervical screening)
    - Late disease: Back pain, Leg edema
  4. Contraceptive / Sexual history
    - OC pills
    - ***Sexually active? (or Had been?)
  5. Cervical smear history
    - Regular screening?
    - Last one?
    - Results?
  6. Obstetric history
    - Parity
  7. Family history
    - ***not related
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Physical examination of Cervical cancer

A

General examination

Pelvic examination
1. Normal appearance cervix in early stage + ***Asymptomatic (∴ cervical cancer screening is effective)

  1. Growth on cervix
    - **Exophytic (cauliflower, contact bleeding)
    - **
    Endophytic (infiltrative, barrel shape cervix)
    - ***Ulceration
    –> must take cervical biopsy to confirm nature of lesion
  2. PV + PR examination (SpC Revision)
    - ***Clinical staging: Assess extent of vaginal + parametrial spread
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Investigations of Cervical cancer

A

Diagnosis
1. Punch biopsy

Plan of management
1. Blood test
- CBP
- LRFT

  1. Tumour markers
    - SCC: SCC Ag level
    - Adenocarcinoma: CA125 (SpC OG)
  2. Imaging
    - CT
    - MRI abdomen + pelvis
    - PET-CT
    - PET-MRI
    –> assess renal tract / extent of spread / LN involvement

(SpC OG
4. Cystoscopy / Sigmoidoscopy (for invasion into bladder / rectosigmoid area
- seldom done now)

  1. Examination under anaesthesia (EUA)
    - for difficult P/E / biopsy
    - seldom done now)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Spread of Cervical cancer

A
  1. Local
    - laterally to parametrium
    - downward to vagina
    - anteriorly to bladder
    - posteriorly to rectum, PoD, sacrum
  2. Distal
    - via LN chains to Pelvic / Para-aortic LN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

***Staging of Cervical cancer

A

FIGO staging
1. Clinical
2. Pathological (新加)
3. Imaging (新加)

Stage 1: Cervix only (5-year survival 85%)
- 1A: Microscopic
—> 1A1: <3mm deep (SpC Revision)
—> 1A2: >=3 to <5mm
- 1B (1-3): Macroscopic, Confined to cervix (1-3 depend on size of mass)
—> 1B1: <2cm in greatest dimension
—> 1B2: >=2 to <4cm
—> 1B3: >=4cm

Stage 2: Upper vagina / Surrounding structures (e.g. parametrium) (5-year survival 75%)
- 2A: Upper 2/3 vagina
- 2B: Parametrium

Stage 3: Lower vagina / Pelvic wall / Pelvic/Para-aortic LN / Hydronephrosis/Non-functioning kidney (5-year survival 50%)
- 3A: Lower 1/3 vagina
- 3B: Pelvic sidewall / Hydronephrosis
- 3C: Pelvic / Para-aortic LN

Stage 4: Bladder / Rectum / Distant metastasis (5-year survival 25%)
- 4A: Bladder, Rectum
- 4B: Distant metastasis

  • Add notation (r: imaging, p: pathology) to indicate findings that are used to allocate case to the stage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment modalities in Cervical cancer

A
  1. Surgery
    - for early stage (e.g. Stage 1)
    - Stage 1A1: Cone biopsy / **Simple hysterectomy: very very early (microscopic **<3mm deep)
    - Stage 1A2: **Wertheim’s hysterectomy (Radical hysterectomy + Pelvic lymphadenectomy)
    –> remove uterus + upper vagina + parametria + pelvic LN
    –> **
    laparotomy (tend to use) / laparoscopic route (↑ recurrence risk + poorer overall survival?)
    - advantages:
    –> preserve Ovarian function (less chance of osteoporosis / heart disease associated with early menopause)
    –> avoid long-term morbidities of Radiotherapy (e.g. bladder, bowel, vaginal stenosis)
    - Stage 1B1, Early 2A: **Radical hysterectomy + Pelvic lymphadenectomy / RT
    - Stage 1B2, Late stage 2 / above: **
    Chemoradiation

(SpC OG
Advantages of Cone vs Hysterectomy:
- preserve fertility
- less invasive / complications

Disadvantages of Cone vs Hysterectomy:
- more difficult to monitor for recurrence after procedure (e.g. in endocervix —> difficult to brush)
- need for re-procedure if margin positive)

  1. ***Radiotherapy
    - for early stage if surgery not suitable / high risk (e.g. elderly with comorbidities)
    - for late stage (e.g. >= Stage 2)
    - External beam + Brachytherapy
  2. ***Chemotherapy
    - in combination with Radiotherapy (Chemoirradiation)
    - to ↑ sensitivity of Radiotherapy
    - for recurrence
    - e.g. Cisplatin
  3. Targeted therapy (Bevacizumab) / Immunotherapy (Pembrolizumab)
    - in combination with Chemotherapy
    - to prolong progression-free survival + overall survival
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prognostic factors in Cervical cancer

A
  1. Stage
  2. LN metastasis (i.e. Stage 3)
  3. Histology
    - common histology (e.g. SCC, Adenocarcinoma, Adenosquamous carcinoma): better prognosis
    - rarer histology (e.g. Neuroendocrine small cell carcinoma): poorer prognosis

SpC Revision:
4. Parametrial involvement
5. Size + Depth of stromal invasion
6. Lymphovascular permeation
7. Age (Controversial)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Endometrial / Corpus cancer (Felix Lai)

A

Types:
1. Type 1 endometrial carcinoma (80%)
- Endometroid histology Grade 1 / 2 (Low-grade) (Endometroid histology is least aggressive)
- Preceded by intraepithelial neoplasm (***Endometrial hyperplasia)
- Estrogen responsive
- Favourable prognosis

  1. Type 2 endometrial carcinoma (10-20%)
    - Endometroid histology Grade 3 (High-grade) + Non-endometroid histology (Serous, Clear cell, Mucinous, Squamous, Transitional cell, Mesonephric, Undifferentiated)
    - NOT clearly associated with estrogen stimulation
    - Poor prognosis

Histological grading:
- Good correlation between grade and prognosis
- Grade 1: Well differentiated, gland forms are conspicuous, mitotic figures are moderately numerous
- Grade 2: Patchy differentiation, gland forms much less prominent and many deposits consist of infiltrating single cell columns / solid masses
- Grade 3: Consist of solid masses of malignant cells of varying sizes and shapes with little / no stroma, mitoses are numerous

Mode of spread:
- Local spread: Myometrium / Cervix / Vaginal / Ovary / Fallopian tubes
- Lymphatic spread: Pelvic + Paraaortic LN
- Distant spread: Lungs

17
Q

Risk factors for Endometrial / Corpus cancer

A
  1. Age
    - A disease of ***post-menopausal women
  2. Excessive ***endogenous estrogen
    - Early menarche
    - Late menopause
    - Nulliparity
    - Obesity
    - PCOS
    - Estrogen-secreting tumours (e.g. Ovarian granulosa cell tumours)
    - Endometrial hyperplasia
  3. ***Exogenous estrogen
    - Unopposed estrogen therapy (uncommon now)
    - Tamoxifen therapy
  4. Miscellaneous
    - Family history of breast, ovarian, CRC cancer
    - ***Lynch syndrome (lifetime risk 15-60% depend on type of mutation)
    - DM
    - HT
18
Q

***Clinical features of Endometrial cancer

A

**Abnormal bleeding
1. Change in menstrual pattern (frequency, duration, volume)
2. Prolonged bleeding
3. **
Intermenstrual bleeding
4. Irregular bleeding
5. ***Post-menopausal bleeding

SpC Revision:
6. Abnormal vaginal discharge
7. Symptoms of late disease (e.g. SOB, back pain)

19
Q

Investigations of Endometrial cancer

A
  1. > 40 yo (be careful!!!)
    - need Endometrial sampling (Endometrial aspirate with Pipelle samplers)
  2. Post-menopausal bleeding
    - ***Transvaginal USG (endometrial thickness >=5mm (>4mm (self notes)): ↑ risk of endometrial pathology) (NOT Transabdominal USG (SpC PP))
  3. **Hysteroscopy + **Biopsy (gold standard)
    - If ***high risk:
    —> Taking Tamoxifen
    —> Endometrial thickness >4mm
    —> Recurrence or refractory symptoms despite treatment for atrophic changes

SpC Revision:
4. Blood test
- CA125 as baseline (for some endometrial cancer)

  1. MRI abdomen / pelvis
    - for depth of myometrial invasion / any distal spread
  2. CXR
20
Q

Spread of Endometrial cancer

A
  1. Locally
    - Cervix
    - Vagina
    - Tubal metastasis
    - Ovarian metastasis
  2. LN
    - via LN chains to Pelvic / Para-aortic LN
21
Q

***Staging of Endometrial cancer

A

FIGO staging: ***Surgically staged!!!

Stage 1: Uterus (5-year survival 85%)
- 1A: No / <50% myometrial invasion
- 1B: >=50% myometrial invasion

Stage 2: Cervix, Cervical stroma but not beyond uterus (5-year survival 75%)

Stage 3: Outside uterus (5-year survival 45%)
- 3A: Serosa of uterus / Adnexa
- 3B: Vaginal / Parametrial
- 3C: Pelvic / Para-aortic LN

Stage 4: Bladder / Rectum / Distant metastasis (5-year survival 25%)
- 4A: Bladder / Rectum
- 4B: Distant (Intraabdominal metastasis / Inguinal LN)

22
Q

Treatment of Endometrial cancer

A

Total hysterectomy + **Bilateral salpingo-oophorectomy (THBSO: **Standard) +/- Lymphadenectomy
- Remove uterus + both ovarian tube + ovaries
- Laparotomy: Size of the uterus **>12 weeks size / Anticipated intra-abdominal **adhesions from previous surgeries
- Laparoscopic: ***Early disease (confined to uterus)

Lymphadenectomy:
- in High risk disease
—> High grade endometrioid carcinoma
—> Deep myometrial invasion
—> Large tumour

High risk group (even LN -ve):
- e.g. Serous carcinoma / Clear cell carcinoma
- **Brachytherapy +/- **Chemo (to ↓ recurrence risk)

LN +ve:
- Need post-op **Chemo +/- **RT (to ↓ recurrence risk)

If LN not done:
- ***External RT if high risk of recurrence

23
Q

Prognosis of Endometrial cancer (SpC Revision)

A

Prognostic factors:
1. Age
2. Stage
3. Histology
4. Spread outside uterus
5. LN involvement

Prognosis:
5-year survival:
- Stage 1A: nearly 90%
- Stage 2: 70%
- Stage 3: 50%
- Stage 4: 20%

24
Q

Summary

A

Cervical cancer:
- Asymptomatic at early stage —> need ***screening

Endometrial cancer:
- Symptomatic at early stage —> presents with ***abnormal bleeding

If treated early, both can have good prognosis

25
Q

Endometrial hyperplasia (SpC OG)

A
  • Proliferation of endometrial glands or irregular size and shape with an increase in endometrial gland: stromal ratio ***>50% compared with normal proliferative endometrium
  • ***Pre-malignant lesion of endometrial adenocarcinoma
  • Diagnosed by ***Endometrial biopsy

Risk factors:
1. Female
2. Obesity
3. Nulliparity
4. Exposure to unopposed endogenous estrogen: PCOS, estrogen-secreting tumour (granulosa cell tumour in ovary)
5. Exogenous estrogen: Tamoxifen, HRT

2 types:
1. Endometrial hyperplasia without atypia (EH)
- Risk of progression: <5%
2. Endometrial hyperplasia with atypia (AH)
- Risk of progression: **30%
- Risk of concomitant carcinoma: **
40-50%

Endometrial hyperplasia without atypia (EH):
1. Early ***H+C
- r/o CA corpus and other pathology

  1. Medical
    - **Levonorgestrel intrauterine system (Mirena) (1st line) (Effective (>90% regression rates))
    - **
    High dose continuous oral progesterone (e.g. norethisterone, medroxyprogesterone actetate)
    (No Depo-provera (self notes))
  2. Surgical
    - ***Hysterectomy (discussed in post-menopausal patients or those on Tamoxifen)

Endometrial hyperplasia with atypia:
1. Surgical
- **Hysterectomy +/- **BSO